This is the limited version of the CV Therapeutics company profile: Join LinkedIn or Sign In to see more information.
CV Therapeutics, Inc. is a biopharmaceutical company headquartered in Palo Alto, CA. Focused on the development of novel small molecule therapeutics for the treatment of cardiovascular diseases, CV Therapeutics has emerged as a leader in cardiovascular medicine.
In April 2009, CV Therapeutics was acquired by Gilead Sciences, Inc.
Your Connections to CV Therapeutics
Popular Profiles at CV Therapeutics
Last edited by Senior Consultant at Deloitte Recap
3172 Porter Drive
Palo Alto, CA
94304
United States
Phone: 650-384-8500
Fax: 650-858-0390
| Headquarters | San Francisco Bay Area |
|---|
| Industry | Biotechnology |
|---|
| Type | Public Company |
|---|
| Status | Acquired |
|---|
| Company Size |
500 employees
|
|---|
| 2008 Revenue |
$154,475,000
|
|---|
| Founded | 1991 |
|---|
| Website | http://www.cvt.com |
|---|
Estimated based on LinkedIn Data
Career path for CV Therapeutics employees
In partnership with 
Send feedback on BusinessWeek/CapIQ content to linkedinissues@capitaliq.com. Copyright © 2009 Capital IQ.
This LinkedIn Company Profile was created by LinkedIn and is about CV Therapeutics. This page is not endorsed by or affiliated with CV Therapeutics. For questions regarding LinkedIn Company Profiles, contact us.
Interactive Data Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions
